Author: Ken Dropiewski

Tenaya Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

TN-201 IND Cleared in January; Plan to Begin Phase 1b Dosing in MYBPC3-associated HCM Patients in Third Quarter 2023 Dosing Commenced in Multiple-Ascending Dose Stage of First-In-Human Clinical Trial of TN-301; Data Anticipated in Second Half 2023 2022 Year End Cash and Investments of $204 Million; Runway to Fund Operations into […]

Cardio Diagnostics Holdings, Inc Announces Financing Agreement with Yorkville Advisors Global, LP of up to $11.2 Million

CHICAGO–(BUSINESS WIRE)–Cardio Diagnostics Holdings, Inc (the “Company”) (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced that it has entered into a securities purchase agreement (“Securities Purchase Agreement”) with YA II PN, Ltd., an investment fund managed by Yorkville Advisors Global, LP (“Yorkville”), under which the Company agreed to […]

Acticor Biotech Successfully Completes a Capital Increase for a Total Gross Amount of 12.2 Million Euros, via the Issuance of 1,793,005 Shares

PARIS–(BUSINESS WIRE)–Regulatory News: Not for release, publication or distribution, directly or indirectly, in the United States of America, Canada, Australia or Japan. This press release does not constitute an offering document and is for information purposes only. ACTICOR BIOTECH (ISIN: FR0014005OJ5 – ALACT – the “Company“), a clinical-stage biotechnology company […]

Heart Muscle Tissue Chips Among Life Science Investigations Launching to ISS on SpaceX CRS-27

KENNEDY SPACE CENTER, Fla., March 8, 2023 /PRNewswire/ — Two tissue chip investigations funded by the National Institutes of Health (NIH) are among the payloads launching on SpaceX’s 27th Commercial Resupply Services (CRS) mission to the International Space Station (ISS). These projects, sponsored by the ISS National Laboratory, will study microgravity’s effects on engineered […]

New Study Highlights Wide Disparities in Access to Life-Saving Mechanical Thrombectomy Stroke Treatment

Mechanical Thrombectomy Global Access For Stroke (MT-GLASS): A Mission Thrombectomy (MT-2020 Plus) Study investigated the determinants of mechanical thrombectomy access for stroke globally WASHINGTON, March 8, 2023 /PRNewswire/ — The Society of Vascular and Interventional Neurology (SVIN) has released a first-ever global analysis of access to mechanical thrombectomy (MT) for treatment of large […]

AdventHealth Opens Dedicated Heart Failure Unit to Provide More Advanced Monitoring to Patients

The new unit at AdventHealth Tampa’s Pepin Heart Institute allows cardiologists to provide advanced therapies that improve outcomes for patients. TAMPA, Fla., March 8, 2023 /PRNewswire/ — AdventHealth Tampa announced a new 20-bed unit dedicated to patients diagnosed with heart failure. The disease affects one in five people over age 40, according […]

Argon Medical Devices Modernizes Portal Vein Access with the Launch of the TRAVELER™ Series

PLANO, Texas, March 7, 2023 /PRNewswire/ — Argon Medical Devices, a leading provider of device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology, introduces the TRAVELER™ Portal Vein Access Series as the newest addition to its portal vein access product portfolio. The product line is designed to meet the challenging needs of […]

FLAME Study Demonstrates 90% Survival Improvement in High-Risk Pulmonary Embolism with Inari Medical FlowTriever System

IRVINE, Calif., March 06, 2023 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced positive results from the FLAME study in high-risk/massive pulmonary embolism (“PE”). The data was […]

Restore Medical Announces Successful First-In-Human Preliminary Results of Its CONTRABAND™ System for Symptomatic Systolic Heart Failure Patients

OR YEHUDA, Israel, March 7, 2023 /PRNewswire/ — Restore Medical Ltd, a privately held medical device company, has successfully completed enrollment of the First In Human clinical study with its CONTRABAND™ device. The world’s first and only Pulmonary Artery Banding (PAB) transcatheter implant is designed to treat heart failure with reduced ejection fraction (HFrEF) and […]

Biosense Webster’s First Dual Energy Catheter to Treat Atrial Fibrillation Begins Evaluation in SmartfIRE Clinical Trial

Study will evaluate THERMOCOOL SMARTTOUCH™ SF Dual Energy Catheter’s potential to enable safer and simpler procedures with the ability to deliver both radiofrequency and pulsed field ablation Irvine, CA – March 7, 2023 – Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i announced […]